Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

YM-905 shows promise as safe and effective treatment for overactive detrusor

April 6, 1998

RS-100975, a prostate-selective alpha-blocker in vitro

April 6, 1998

The alpha1L-adrenoceptor: a new target for BPH therapy

April 6, 1998

American Home Products synthesizes and evaluates new smooth muscle relaxants

April 6, 1998

Takeda claims bicyclic compounds for micturition disorders

April 6, 1998

Dual-action agent for BPH developed at Zeria

April 3, 1998

N-Alkylated saccharins from Merck & Co. with potential in BPH therapy

April 2, 1998

FDA approves DDAVP tablets for nocturnal enuresis in children

April 1, 1998

New vasopressin antagonist from JT with aquaretic effects in animals

April 1, 1998

Detrol approved by FDA for overactive bladder

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...